Saturday 17 October 2026
Export MDRX’s income statement to Excel — free account
Veradigm Inc.
MDRX Healthcare Health Information Services
5.00
0.00
0.00%
Follow MDRX
| Dec '22 | Sep '22 | Jun '22 | Mar '22 | Older periods | |
|---|---|---|---|---|---|
| (7.27%) | 5.07% | 5.21% | 10.12% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
7 | — | 7 | 4 | |
| (4.53%) | 3.15% | 3.17% | 5.79% | ||
ROIC |
(2.20%) | 4.24% | 3.73% | 2.87% | |
Return on Tangible Assets |
(18.85%) | 11.55% | 11.48% | 16.98% | |
Average Days of Receivables |
73.96 | 102.25 | 102.09 | 106.12 | |
Free Cash Flow per Share |
0.75 | 1.07 | 1.25 | (0.47) | |
Free Cash Flow |
84.56 | 117.80 | 143.04 | (54.89) | |
Capital Expenditures |
(32.27) | (41.82) | (44.33) | (42.96) | |
| Other line items | |||||
Cash ROIC |
5.08% | 6.30% | 7.54% | (3.03%) | |
Accounts Receivable Turnover |
4.92 | 2.37 | 2.36 | 2.11 | |
Accounts Payable Turnover |
16.94 | 16.60 | 13.04 | 13.83 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
40.26 | 16.12 | 22.51 | 19.34 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.70) | (0.07) | (0.01) | (0.09) | |
Research and Development Expense of Revenue |
16.65% | 15.13% | 14.87% | 14.81% | |
Selling, General and Administrative Expense of Revenue |
28.77% | 26.15% | 25.60% | 20.62% | |
Share Based Compensation of Revenue |
4.27% | 3.80% | 3.75% | 2.61% | |
Interest Coverage |
(4.27) | 3.47 | 2.43 | 3.13 | |
Operating CF/Net income |
(1.35) | 2.43 | 2.78 | (0.08) | |
Depreciation/Fixed assets |
11.15 | 5.64 | 4.56 | 7.59 | |
Capex/Depreciation |
(0.31) | (0.63) | (0.65) | (0.61) | |
Revenue per Share |
5.25 | 5.48 | 5.22 | 5.06 | |
Operating CF per Share |
1.04 | 1.45 | 1.64 | (0.10) | |
Capex per Share |
(0.29) | (0.38) | (0.39) | (0.37) | |
Capex to Sales |
0.05 | 0.07 | 0.07 | 0.07 |
Columns are period end dates · fundamentals updated 1 Oct 2026